Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | UBE2D2 |
| Upstream (Parents) |
|---|
| (<<) ALDOA → UBE2D2 |
| (<<) CHST3 → UBE2D2 |
| (<<) CREB1 → UBE2D2 |
| (<<) GPX1 → UBE2D2 |
| (<<) HDAC3 → UBE2D2 |
| (<<) HDAC4 → UBE2D2 |
| (<<) KIAA1199 → UBE2D2 |
| (<<) PRR5 → UBE2D2 |
| (<<) RAD51L3 → UBE2D2 |
| (<<) RHOT2 → UBE2D2 |
| (<<) RPL26L1 → UBE2D2 |
| (<<) RTN3 → UBE2D2 |
| (<<) SERPINB1 → UBE2D2 |
| (<<) TRAF6 → UBE2D2 |
| (<<) VEGFB → UBE2D2 |
| Downstream (Children) |
|---|
| UBE2D2 → CSNK1A1 (>>) |
| UBE2D2 → MYCN (>>) |
| UBE2D2 → MYL6B (>>) |
| UBE2D2 → NFKB1 (>>) |
| UBE2D2 → SMAD5 (>>) |
